)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Cantargia
Cantargia (CANTA) investor relations material
Cantargia Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Feb, 2026
Executive summary
Achieved a transformational year with the Otsuka partnership for CAN10, validating the IL1RAP platform and strengthening financials.
Advanced nadunolimab to pivotal trial readiness in PDAC, supported by FDA Fast Track designation and new investigator-initiated studies in colorectal cancer.
Strengthened leadership with the appointment of Dr. Wolfram Dempke as Chief Medical Officer and organizational enhancements.
Focused on operational excellence, execution, and value creation for shareholders, preparing for pivotal late-stage trials in 2026.
Broadened external validation through strategic partnerships and active capital market engagement.
Financial highlights
Full-year 2025 revenues reached SEK 316.7 million, with operating expenses of SEK 162.6 million and net profit of SEK 147 million (EPS: 0.59 SEK).
Q4 2025 revenues were SEK 8 million, with operating expenses of SEK 36.4 million and a net loss of SEK 32.3 million (EPS: -0.13 SEK).
Cash and cash equivalents at year-end were approximately SEK 282 million, providing a runway into 2028 with current commitments.
No dividend proposed for the year.
Rights issue in late 2024 raised SEK 120 million gross, boosting cash position.
Outlook and guidance
Pivotal trial for nadunolimab in PDAC planned to initiate in 2026, with interim analysis and potential accelerated approval in 2028, subject to regulatory and funding milestones.
CAN14 candidate selection expected by year-end 2026.
No milestone payments from Otsuka or other collaborations anticipated in 2026.
Cash runway expected to fund ongoing commitments for nadunolimab and next-generation IL1RAP antibodies into 2028, excluding potential milestones.
Priorities include finalizing pivotal trial design, diagnostic validation, securing financing, and maintaining operational rigor.
Detail PDAC pivotal trial funding strategy
What drives no CAN10 milestones in 2026?
What is the strategic rationale for CAN14's second target?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Cantargia earnings date
Q1 202619 May, 2026
Cantargia
Next Cantargia earnings date
Q1 202619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cantargia AB, a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Its lead product is CAN04, an antibody directed the interleukin-1 receptor accessory protein that targets cancer cells that express IL1RAP on their surface; and CAN04 is currently being developed in two clinical programs, one focusing on treatment of lung cancer and another on treatment of pancreatic cancer. Cantargia AB was founded in 2010 and is based in Lund, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage